The dual impact of ACE2 in COVID-19 and ironical actions in geriatrics and pediatrics with possible therapeutic solutions

T Behl, I Kaur, S Bungau, A Kumar, MS Uddin, C Kumar… - Life Sciences, 2020 - Elsevier
The novel corona virus disease has shaken the entire world with its deadly effects and rapid
transmission rates, posing a significant challenge to the healthcare authorities to develop …

[HTML][HTML] Do all opioid drugs share the same immunomodulatory properties? A review from animal and human studies

S Franchi, G Moschetti, G Amodeo… - Frontiers in …, 2019 - frontiersin.org
Suppression of the immune system has been constantly reported in the last years as a
classical side effect of opioid drugs. Most of the studies on the immunological properties of …

Influence of opioids on immune function in patients with cancer pain: from bench to bedside

JW Boland, AG Pockley - British journal of pharmacology, 2018 - Wiley Online Library
In patients with cancer, opioids are principally used for the management of acute surgical
and chronic cancer‐related pain. However, opioids have many non‐analgesic effects …

Current knowledge of buprenorphine and its unique pharmacological profile

J Pergolizzi, AM Aloisi, A Dahan, J Filitz… - Pain …, 2010 - Wiley Online Library
Despite the increasing clinical use of transdermal buprenorphine, questions have persisted
about the possibility of a ceiling effect for analgesia, its combination with other μ‐opioid …

[图书][B] Karch's pathology of drug abuse

SB Karch, O Drummer - 2008 - taylorfrancis.com
Written for practitioners in the field, this critically acclaimed bestseller provides authoritative
information focused on the investigation of drug-related deaths and practical approaches to …

Opioids and the immune system

P Sacerdote - Palliative medicine, 2006 - journals.sagepub.com
Opioid compounds such as morphine produce powerful analgesia that is effective in treating
various types of pain. In addition to their therapeutic efficacy, opioids can produce several …

Modeling sepsis in the laboratory: merging sound science with animal well-being

JA Nemzek, K Hugunin, MR Opp - Comparative medicine, 2008 - ingentaconnect.com
Despite impressive advances in biomedical research, few noteworthy breakthroughs have
been made in the treatment of sepsis during the past several decades. This stalemate is …

[PDF][PDF] Opioid guidelines in the management of chronic non-cancer pain

AM Trescot, MV Boswell, SL Atluri, HC Hansen… - Pain physician, 2006 - academia.edu
Background: Opioid abuse has increased at an alarming rate. However, available evidence
suggests a wide variance in the use of opioids, as documented by different medical …

[PDF][PDF] Twelve reasons for considering buprenorphine as a frontline analgesic in the management of pain

MP Davis - J Support Oncol, 2012 - academia.edu
Buprenorphine is an opioid that has a complex and unique pharmacology which provides
some advantages over other potent mu agonists. We review 12 reasons for considering …

Clinical update on the pharmacology, efficacy and safety of transdermal buprenorphine

HG Kress - European Journal of Pain, 2009 - Elsevier
Buprenorphine was not used widely in clinical practice over many years, mainly due to
analgesic potency and clinical safety concerns based on misinterpreted animal data …